Bright Health Group, Inc.

EDGAR

Annual consolidated revenue for 2024: about USD 936.7M, using the latest reported figures. The previous period, 2023, was about USD 1.161B.

Watchlist

Latest quarter

Revenue

209 million USD

2025 Q2 · USD

Exact inputs and evidence

Operating margin

6.82%

2025 Q2 · %

Exact inputs and evidence
  • Operating Income: 14257000 USD Source
  • Revenue: 209082000 USD Source

Operating cash flow

-2.83 million USD

2025 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -23875000 USD Source
  • Operating Cash Flow: -21049000 USD Source

Free cash flow

-4.45 million USD

2025 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -23875000 USD Source
  • Operating Cash Flow: -21049000 USD Source
  • Capital Expenditure: 2653000 USD Source
  • Capital Expenditure: 1026000 USD Source
Cash and cash equivalents
132 million USD Source
Exact value

131618000 USD

Long-term debt including current maturities
197 million USD Source
Exact value

197350000 USD

Shares outstanding
9.02 million shares Source
Exact value

9024240 shares

Reported share-count change

9.00% · 745 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 8279173 shares · 2024-06-30· Source
  • 9024240 shares · 2025-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

890 million USD

2024-07-01 – 2025-06-30

Exact inputs and evidence
  • Revenue: 232933000 USD · 2024-07-01 – 2024-09-30 Source
  • Revenue: 936657000 USD · 2024-01-01 – 2024-12-31 Source
  • Revenue: 704019000 USD · 2024-01-01 – 2024-09-30 Source
  • Revenue: 215787000 USD · 2025-01-01 – 2025-03-31 Source
  • Revenue: 209082000 USD · 2025-04-01 – 2025-06-30 Source

Operating cash flow

-69.9 million USD

2024-07-01 – 2025-06-30

Exact inputs and evidence
  • Operating cash flow: -98823000 USD · 2024-01-01 – 2024-09-30 Source
  • Operating cash flow: -77148000 USD · 2024-01-01 – 2024-06-30 Source
  • Operating cash flow: -123217000 USD · 2024-01-01 – 2024-12-31 Source
  • Operating cash flow: -98823000 USD · 2024-01-01 – 2024-09-30 Source
  • Operating cash flow: -21049000 USD · 2025-01-01 – 2025-03-31 Source
  • Operating cash flow: -23875000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: -21049000 USD · 2025-01-01 – 2025-03-31 Source

Capital expenditure

4.11 million USD

2024-07-01 – 2025-06-30

Exact inputs and evidence
  • Capital expenditure: 1542000 USD · 2024-01-01 – 2024-09-30 Source
  • Capital expenditure: 877000 USD · 2024-01-01 – 2024-06-30 Source
  • Capital expenditure: 2333000 USD · 2024-01-01 – 2024-12-31 Source
  • Capital expenditure: 1542000 USD · 2024-01-01 – 2024-09-30 Source
  • Capital expenditure: 1026000 USD · 2025-01-01 – 2025-03-31 Source
  • Capital expenditure: 2653000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 1026000 USD · 2025-01-01 – 2025-03-31 Source

Free cash flow

-74.1 million USD

2024-07-01 – 2025-06-30

Exact inputs and evidence
  • Operating cash flow: -98823000 USD · 2024-01-01 – 2024-09-30 Source
  • Operating cash flow: -77148000 USD · 2024-01-01 – 2024-06-30 Source
  • Operating cash flow: -123217000 USD · 2024-01-01 – 2024-12-31 Source
  • Operating cash flow: -98823000 USD · 2024-01-01 – 2024-09-30 Source
  • Operating cash flow: -21049000 USD · 2025-01-01 – 2025-03-31 Source
  • Operating cash flow: -23875000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: -21049000 USD · 2025-01-01 – 2025-03-31 Source
  • Capital expenditure: 1542000 USD · 2024-01-01 – 2024-09-30 Source
  • Capital expenditure: 877000 USD · 2024-01-01 – 2024-06-30 Source
  • Capital expenditure: 2333000 USD · 2024-01-01 – 2024-12-31 Source
  • Capital expenditure: 1542000 USD · 2024-01-01 – 2024-09-30 Source
  • Capital expenditure: 1026000 USD · 2025-01-01 – 2025-03-31 Source
  • Capital expenditure: 2653000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 1026000 USD · 2025-01-01 – 2025-03-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2025-08-07.

Financial data available through: 2024-12-31.

Coverage by financial measure
  • Revenue: 6 of 11 periods available· newest 2024-12-31
  • Operating income: 6 of 11 periods available· newest 2024-12-31
  • Net income: 6 of 11 periods available· newest 2024-12-31
  • Operating cash flow: 6 of 11 periods available· newest 2024-12-31
  • Capital expenditure: 6 of 11 periods available· newest 2024-12-31
  • Total assets: 5 of 11 periods available· newest 2024-12-31
  • Total liabilities: 5 of 11 periods available· newest 2024-12-31
  • Current assets: 5 of 11 periods available· newest 2024-12-31
  • Current liabilities: 5 of 11 periods available· newest 2024-12-31
  • Cash and cash equivalents: 5 of 11 periods available· newest 2024-12-31
  • Long-term debt including current maturities: 3 of 11 periods available· newest 2024-12-31
  • Shares outstanding: 5 of 11 periods available· newest 2024-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    -19.3%

    Prior period

    USD 1.16 billion

    –

    Current period

    USD 936.66 million

    –

    Exact inputs and evidence

    936657000 − 1160802000 = -224145000 USD

    1160802000 USD · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    936657000 USD · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +USD 1.02 billion

    Prior period

    −USD 1.15 billion

    –

    Current period

    −USD 134.68 million

    –

    Exact inputs and evidence

    -134680000 − -1151454000 = 1016774000 USD

    -1151454000 USD · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    -134680000 USD · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 2.6 billion

    Prior period

    −USD 2.73 billion

    –

    Current period

    −USD 123.22 million

    –

    Exact inputs and evidence

    -123217000 − -2726546000 = 2603329000 USD

    -2726546000 USD · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    -123217000 USD · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -19.5%

    Prior period

    USD 2.9 million

    –

    Current period

    USD 2.33 million

    –

    Exact inputs and evidence

    2333000 − 2897000 = -564000 USD

    2897000 USD · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    2333000 USD · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2024-01-01 – 2024-12-31

  • Revenue USD 936.66 million 100% of revenue
  • Operating costs Derived USD 1.04 billion 111% of revenue
  • Operating income −USD 107.41 million −11% of revenue
  • Tax, interest and other Derived USD 27.27 million 2.9% of revenue
  • Net income −USD 134.68 million −14% of revenue

Cash

  • Operating cash flow −USD 123.22 million −13% of revenue
  • Capital expenditure USD 2.33 million 0.2% of revenue
  • Free cash flow Derived −USD 125.55 million −13% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2019 Operating loss: operating costs were 145% of revenue.
  • 2020 Operating loss: operating costs were 133% of revenue.
  • 2021 Operating loss: operating costs were 123% of revenue.
  • 2022 Operating loss: operating costs were 149% of revenue.
  • 2023 Operating loss: operating costs were 150% of revenue.
  • 2024 Operating loss: operating costs were 111% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2019 2019-01-01 – 2019-12-31280673000 406010000 Derived -125337000 0 Derived -125337000 -9001000 Derived
Source
2020 2020-01-01 – 2020-12-31514887000 685270000 Derived -170383000 78059000 Derived -248442000 -63712000 Derived
Source
2021 2021-01-01 – 2021-12-311513033000 1856660000 Derived -343627000 841235000 Derived -1184862000 51645000 Derived
Source
2022 2022-01-01 – 2022-12-31751163000 1119919000 Derived -368756000 1086788000 Derived -1455544000 207018000 Derived
Source
2023 2023-01-01 – 2023-12-311160802000 1737798000 Derived -576996000 574458000 Derived -1151454000 -2729443000 Derived
Source
2024 2024-01-01 – 2024-12-31936657000 1044067000 Derived -107410000 27270000 Derived -134680000 -125550000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 936.7M 2024
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.6B1.2B817.0M408.5M0.0201920222024
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2019Revenue280673000
2020Revenue514887000
2021Revenue1513033000
2022Revenue751163000
2023Revenue1160802000
2024Revenue936657000

Revenue growth

Change in revenue from the same financial period one year earlier.

-19.3% 2024
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.213%143%72%1%-70%201920222024
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2019Year over yearNo prior comparable period
2020Year over year83.4%
2021Year over year193.9%
2022Year over year-50.4%
2023Year over year54.5%
2024Year over year-19.3%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -11.5% 2024
Net margin -14.4% 2024
Free cash flow margin -13.4% 2024
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.49%-28%-104%-180%-256%201920222024
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2019Operating margin-44.7%
2020Operating margin-33.1%
2021Operating margin-22.7%
2022Operating margin-49.1%
2023Operating margin-49.7%
2024Operating margin-11.5%
2019Net margin-44.7%
2020Net margin-48.3%
2021Net margin-78.3%
2022Net margin-193.8%
2023Net margin-99.2%
2024Net margin-14.4%
2019Free cash flow margin-3.2%
2020Free cash flow margin-12.4%
2021Free cash flow margin3.4%
2022Free cash flow margin27.6%
2023Free cash flow margin-235.1%
2024Free cash flow margin-13.4%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -123.2M 2024
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.471.3M-387.3M-1.2B-2.1B-3.0B201920222024
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2019Operating cash flow-8208000
2020Operating cash flow-57238000
2021Operating cash flow82059000
2022Operating cash flow234466000
2023Operating cash flow-2726546000
2024Operating cash flow-123217000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -125.6M 2024
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.441.9M-409.6M-1.3B-2.1B-3.0B201920222024
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2019Free cash flow-9001000
2020Free cash flow-63712000
2021Free cash flow51645000
2022Free cash flow207018000
2023Free cash flow-2729443000
2024Free cash flow-125550000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

170.9% 2024
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.185%138%92%46%0%2019-12-3120222024
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2019-12-31Liabilities / assetsNot reportedNo source recorded
2020Liabilities / assets32.8%
2021Liabilities / assets64.6%
2022Liabilities / assets79.9%
2023Liabilities / assets120.8%
2024Liabilities / assets170.9%

Current assets to current liabilities

Current assets divided by current liabilities.

0.61× 2024
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.2.25×1.69×1.13×0.56×0.00×2019-12-3120222024
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2019-12-31Current assets / current liabilitiesNot reportedNo source recorded
2020Current assets / current liabilities2.09×
2021Current assets / current liabilities0.73×
2022Current assets / current liabilities0.97×
2023Current assets / current liabilities0.78×
2024Current assets / current liabilities0.61×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2019 2019-01-01 – 2019-12-31
−USD 125.34 million
Exact value

Exact value: -125337000 USD

2019-01-01 – 2019-12-31: -125337000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 8.21 million
Exact value

Exact value: -8208000 USD

2019-01-01 – 2019-12-31: -8208000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 793,000
Exact value

Exact value: 793000 USD

2019-01-01 – 2019-12-31: 793000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 9 million
Calculation and evidence

-8208000 − 793000 USD

Exact free cash flow: -9001000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 248.44 million
Exact value

Exact value: -248442000 USD

2020-01-01 – 2020-12-31: -248442000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 57.24 million
Exact value

Exact value: -57238000 USD

2020-01-01 – 2020-12-31: -57238000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 6.47 million
Exact value

Exact value: 6474000 USD

2020-01-01 – 2020-12-31: 6474000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 63.71 million
Calculation and evidence

-57238000 − 6474000 USD

Exact free cash flow: -63712000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 1.18 billion
Exact value

Exact value: -1184862000 USD

2021-01-01 – 2021-12-31: -1184862000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 82.06 million
Exact value

Exact value: 82059000 USD

2021-01-01 – 2021-12-31: 82059000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 30.41 million
Exact value

Exact value: 30414000 USD

2021-01-01 – 2021-12-31: 30414000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 51.65 million
Calculation and evidence

82059000 − 30414000 USD

Exact free cash flow: 51645000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 1.46 billion
Exact value

Exact value: -1455544000 USD

2022-01-01 – 2022-12-31: -1455544000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 234.47 million
Exact value

Exact value: 234466000 USD

2022-01-01 – 2022-12-31: 234466000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 27.45 million
Exact value

Exact value: 27448000 USD

2022-01-01 – 2022-12-31: 27448000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 207.02 million
Calculation and evidence

234466000 − 27448000 USD

Exact free cash flow: 207018000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 1.15 billion
Exact value

Exact value: -1151454000 USD

2023-01-01 – 2023-12-31: -1151454000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 2.73 billion
Exact value

Exact value: -2726546000 USD

2023-01-01 – 2023-12-31: -2726546000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 2.9 million
Exact value

Exact value: 2897000 USD

2023-01-01 – 2023-12-31: 2897000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 2.73 billion
Calculation and evidence

-2726546000 − 2897000 USD

Exact free cash flow: -2729443000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 134.68 million
Exact value

Exact value: -134680000 USD

2024-01-01 – 2024-12-31: -134680000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 123.22 million
Exact value

Exact value: -123217000 USD

2024-01-01 – 2024-12-31: -123217000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 2.33 million
Exact value

Exact value: 2333000 USD

2024-01-01 – 2024-12-31: 2333000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 125.55 million
Calculation and evidence

-123217000 − 2333000 USD

Exact free cash flow: -125550000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

20 filings · 3,129 latest values · 3,113 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001671284, 1671284, BHG, NEUE, edgar:1671284

Also known as BRIGHT HEALTH GROUP, INC., Bright Health Group Inc., Bright Health Group, Inc., Bright Health Inc., NEUEHEALTH, INC., NeueHealth, Inc.